Patel Chem Specialities Limited IPO

Patel Chem Specialities is coming up with its SME IPO to be listed on BSE NSE tentatively on 30th July, 2025, in order to raise around ₹58.80 crore through their fresh issue. Patel Chem Specialities IPO will be opening for subscription on 25th July, 2025 and the IPO will close by 29th July, 2025. The issue comprises 70 Lakh fresh equity shares with the price band set at ₹82 to ₹84 per share. The minimum lot size for any applicant is 1,600 and retail investors need to apply for a minimum of 3,200 shares, amounting up to ₹2,62,400 while HNIs need to apply for a minimum of 4,800 shares which totals up to ₹4,03,200.

Company Background

Patel Chem Specialities Limited is the growing manufacturer of high-quality pharmaceutical excipients as well as speciality chemicals, it caters to food, cosmetics, pharmaceuticals and various other industrial sectors. With an international footprint spread across regions like the Middle East, North America, Southeast Asia, Europe and East Asia, the company offers products like Rheollose, Disolwell, Blowtab, Swellcal, Hindcel, Pharlub, AmyloTab and Sodium Chloro Acetate.

Operations and Product Range

Facility and Production

Patel Chem was incorporated in the year 2008 in Gujarat, and specialises in manufacturing of pharmaceutical products like Sodium Starch Glycolate (SSG), Croscarmellose sodium (CCS), Sodium CMC, pregelatinised starch, Calcium CMC, Magnesium stearate and also producing key API intermediate Sodium Monochloroacetate. The corporation is well-established in India and globally across the Middle East, Asian and US region.

Brand and Market Presence

With improving margins, high-revenue and a diversified customer base the company is aiming for its growth in the speciality chemical segments with products that act like binders, gelling agents, disintegrants, thickeners as well as stabilizers. In 2025 the company reported exports of its pharmaceutical excipients to more than 15 countries. The company’s presence is backed by its diversified clientele of more than 350 clients across multiple industries.

Revenue Channels

Patel Chem registers a revenue of ₹105.55 crore in FY 2025 with an increase from ₹82.72 crore in FY 2024, reflecting a 28% growth in topline, the company gains most of its revenue through -

1. • Export of products to various companies such as Japan, USA, Germany and South Korea with most of its exports revenue coming from Egypt.
2. • The company caters to clients from various industrial sectors such as textiles, rubber, paint, construction, etc. creating a diversified revenue base.
3. • Its Pharmaceutical excipients are the key area of focus that helps in generating most part of the company’s revenue.

Their multi-dimensional approach in order to raise revenue gives the company a strong presence in the market as well as diminishes risk of dependency on a single line of revenue generation.

Management & Shareholding

Promoters & Shareholding

The promoters of Patel Chem Specialities IPO are Bhupesh Patel, Anshu Patel and Vini Patel who hold significant equity in the Pre-IPO stage and intend to maintain their majority control post-listing. The lead manager and registrar for the IPO are -

1. 1. Book running lead manager - Cumulative Capital Pvt. Limited
2. 2. Designated market maker - Globalworth Securities Limited
3. 3. Registrar to the issue - MUFG Intime India Pvt. Limited

Board Members

The board members of Patel Chem Specialities Limited, as of 2025 are, Bhupesh Vahalabhai Patel (Managing Director), Anshu Bhupesh Patel (Whole-time Director), Vini Bhupesh Patel (Director) and Himani Vatsal Shah (Director). Their managerial expertise helps in overseeing the company’s operations and strategic functions.